One tumor-promoting mechanism could be immune response inhibition by tumor antigen presentation via MHC class II receptors present on the macrophage-tumor cell hybrids, directly affecting the CD4+ T cell responses, which could be targeted therapeutically [5,127]. Here, CD4 is linked to neoplasm.